EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Contribution of the Serotonin 5‐ HT 2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress

Daisuke Ibi, Rika Takaba, Keisuke Yoshida, Ririna Kawase, Hiroko Kitagawa, Momoko Matsushita, Kana Ito, Shoya Uno, Fumiya Nishimura, Shinji Kitagaki, Masayuki Hiramatsu

Neuropsychopharmacology Reports · 2026

DOI: 10.1002/npr2.70152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, 2026. Verfasst von Daisuke Ibi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan. Hauptthemen laut MEDLINE: Receptor, Serotonin, 5-HT2A, Social Defeat, Psilocybin, Stress, Psychological. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SENSHIN Medical Research Foundation, Research Foundation for Pharmaceutical Sciences, Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychedelics such as psilocybin and lysergic acid diethylamide (LSD) exert hallucinogenic effects through stimulation of serotonin 5‐HT 2A receptors (5‐HT2ARs) in the cerebral cortex. In recent years, numerous reports have demonstrated that psychedelics are effective in treating various psychiatric disorders such as major depressive disorder (MDD), treatment‐resistant depression (TRD), and anxiety‐related disorders. We have previously reported that administration of psilocin, the active metabolite of psilocybin, produces antidepressant‐like effects in mice. Furthermore, we found that this effect is mediated by 5‐HT2AR activation. Since depression and other psychiatric disorders often lead to impairments in social behavior (e.g., social avoidance), the present study examined the effects of psilocin on social avoidance behavior in mice subjected to chronic social defeat stress (CSDS), a widely used model that closely models human psychosocial stress. Mice exposed to CSDS exhibited social avoidance behavior, whereas psilocin administration before the onset of CSDS had little effect on this behavior. In contrast, psilocin administration after the completion of CSDS ameliorated social avoidance in CSDS‐exposed mice. This effect was blocked by pretreatment with a 5‐HT2AR antagonist, indicating that psilocin exerts its therapeutic effects through 5‐HT2AR activation. Taken together, psilocin exerts therapeutic effects on social avoidance behavior after stress through activation of 5‐HT2AR, but not preventive effects when administered before stress, suggesting that psilocin may promote stress resilience rather than resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Serotonin, 5-HT2ASocial DefeatPsilocybinStress, PsychologicalSocial BehaviorHallucinogensAnimalsMaleMiceSerotonin 5-HT2 Receptor AntagonistsSerotonin 5-HT2 Receptor AgonistsMice, Inbred C57BLBehavior, Animal

Stichwörter der Autor:innen

psilocinserotonin 5‐HT2A receptorsocial defeat stress

Substanzen

Receptor, Serotonin, 5-HT2APsilocybinHallucinogenspsilocinSerotonin 5-HT2 Receptor AntagonistsSerotonin 5-HT2 Receptor Agonists

Autor:innen und Institutionen

  • Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
  • Department of Chemical Pharmacology, Graduate School of Pharmacy, Meijo University, Nagoya, Japan.
  • Department of Medicinal Chemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan.

Förderung

  • SENSHIN Medical Research Foundation
  • Research Foundation for Pharmaceutical Sciences
  • Takeda Science Foundation
  • Brain Science Foundation
  • NOVARTIS Foundation (Japan) for the Promotion of Science
  • Smoking Research Foundation
  • Hori Sciences and Arts Foundation
  • Takahashi Industrial and Economic Research Foundation

Zitieren

APA

Ibi, D., Takaba, R., Yoshida, K., Kawase, R., Kitagawa, H., Matsushita, M., Ito, K., Uno, S., Nishimura, F., Kitagaki, S., & Hiramatsu, M. (2026). Contribution of the Serotonin 5‐ HT 2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.70152

Vancouver

Ibi D, Takaba R, Yoshida K, Kawase R, Kitagawa H, Matsushita M, et al. Contribution of the Serotonin 5‐ HT 2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress. Neuropsychopharmacology Reports. 2026. doi:10.1002/npr2.70152

BibTeX
@article{Ibi2026,
  author = {Ibi, Daisuke and Takaba, Rika and Yoshida, Keisuke and Kawase, Ririna and Kitagawa, Hiroko and Matsushita, Momoko and Ito, Kana and Uno, Shoya and Nishimura, Fumiya and Kitagaki, Shinji and Hiramatsu, Masayuki},
  title = {Contribution of the Serotonin 5‐ HT 2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress},
  journal = {Neuropsychopharmacology Reports},
  year = {2026},
  doi = {10.1002/npr2.70152}
}
Kostenlos starten →